0

Journal Articles

in Hepatobiliary Cancer
 41-60 of 147 Articles
JAMA | 
From the Centers for Disease Control and Prevention |  June 16, 2010 FREE
Hepatocellular Carcinoma—United States, 2001-2006
JAMA. 2010;303(23):2349-2350. doi:.
JAMA Surgery | 
Invited Critique |  April 01, 2010
Positron Emission Tomography for Colorectal Cancer Liver Metastases: Where”s the Value?:  Comment on “Effectiveness of Positron Emission Tomography for Predicting Chemotherapy Response in Colorectal Cancer Liver Metastases”
James C. Hebert, MD
Arch Surg. 2010;145(4):345. doi:10.1001/archsurg.2010.14.
JAMA Surgery | 
Original Article |  April 01, 2010 FREE
Effectiveness of Positron Emission Tomography for Predicting Chemotherapy Response in Colorectal Cancer Liver Metastases
Evan S. Glazer, MD; Karen Beaty, PA–C; Eddie K. Abdalla, MD; et al.
Arch Surg. 2010;145(4):340-345. doi:10.1001/archsurg.2010.41.
JAMA | 
Original Contribution |  March 17, 2010 FREE
Imaging Response in the Primary Index Lesion and Clinical Outcomes Following Transarterial Locoregional Therapy for Hepatocellular Carcinoma
Ahsun Riaz, MD; Frank H. Miller, MD; Laura M. Kulik, MD; et al.
JAMA. 2010;303(11):1062-1069. doi:10.1001/jama.2010.262.
INCLUDES: , Supplemental Content
JAMA Surgery | 
Original Article |  March 01, 2010 FREE
Identification of Unknown Primary Tumors in Patients With Neuroendocrine Liver Metastases
Sam C. Wang, MD; Justin R. Parekh, MD; Marlene B. Zuraek, MD; et al.
Arch Surg. 2010;145(3):276-280. doi:10.1001/archsurg.2010.10.
JAMA Surgery | 
Invited Critique |  February 01, 2010
Planned Laparoscopic Approach for Early-Stage Gallbladder Cancer: The Glass Is One-Third Full:  Comment on
Jeffrey B. Matthews, MD
Arch Surg. 2010;145(2):133. doi:10.1001/archsurg.2009.262.
JAMA | 
Preliminary Communication |  December 02, 2009 FREE
Association of Computed Tomography Morphologic Criteria With Pathologic Response and Survival in Patients Treated With Bevacizumab for Colorectal Liver Metastases
Yun Shin Chun, MD; Jean-Nicolas Vauthey, MD; Piyaporn Boonsirikamchai, MD; et al.
JAMA. 2009;302(21):2338-2344. doi:10.1001/jama.2009.1755.
JAMA | 
The World in Medicine |  November 18, 2009
MicroRNA and Liver Cancer
Joan Stephenson, PhD
JAMA. 2009;302(19):2083. doi:10.1001/jama.2009.1682.
JAMA Surgery | 
Special Feature |  July 20, 2009 FREE
Image of the Month—Quiz Case
Theodore Maglione, BS; Sherri Yong, MD; Milind Velankar, MD; et al.
Arch Surg. 2009;144(7):691-692. doi:10.1001/archsurg.2009.119-a.
JAMA Surgery | 
Special Feature |  July 20, 2009 FREE
Image of the Month—Diagnosis
Arch Surg. 2009;144(7):691-692. doi:10.1001/archsurg.2009.119-b.
JAMA Surgery | 
Invited Critique |  May 18, 2009
Trends in Presentation and Survival for Gallbladder Cancer During a Period of More Than 4 Decades—Invited Critique
Laurence McCahill, MD
Arch Surg. 2009;144(5):447. doi:10.1001/archsurg.2009.55.
JAMA Surgery | 
Special Feature |  May 18, 2009 FREE
Image of the Month—Quiz Case
Renato Costi, MD, PhD; Nathalie Bataille, MD; Alain Cazaban, MD; et al.
Arch Surg. 2009;144(5):481-482. doi:10.1001/archsurg.2009.64-a.
JAMA Surgery | 
Paper |  May 18, 2009 FREE
Trends in Presentation and Survival for Gallbladder Cancer During a Period of More Than 4 Decades:  A Single-Institution Experience
Ioannis T. Konstantinidis, MD; Vikram Deshpande, MD; Muriel Genevay, MD; et al.
Arch Surg. 2009;144(5):441-447. doi:10.1001/archsurg.2009.46.
JAMA | 
Editorial |  May 13, 2009
Retraction: Cheng B-Q, et al. Chemoembolization combined with radiofrequency ablation for patients with hepatocellular carcinoma larger than 3 cm: a randomized controlled trial. JAMA. 2008;299(14):1669-1677.
Catherine D. DeAngelis, MD, MPH; Phil B. Fontanarosa, MD, MBA
JAMA. 2009;301(18):1931. doi:10.1001/jama.2009.640.
JAMA Ophthalmology | 
Clinical Sciences |  May 11, 2009 FREE
Hepatic Metastasis From Uveal Melanoma:  Angiographic Pattern Predictive of Survival After Hepatic Arterial Chemoembolization
Pouya N. Dayani, MD; Jennifer E. Gould, MD; Daniel B. Brown, MD; et al.
Arch Ophthalmol. 2009;127(5):628-632. doi:10.1001/archophthalmol.2009.45.
JAMA Surgery | 
Special Feature |  March 16, 2009 FREE
Image of the Month—Quiz Case
Ajay Jain, MD; Christopher Smith, MD; Jean-Francois H. Geschwind, MD; et al.
Arch Surg. 2009;144(3):285-286. doi:10.1001/archsurg.2008.578-a.
JAMA Surgery | 
Correspondence |  December 15, 2008
Treatment of Stage IVA Hepatocellular Carcinoma
Martin Palavecino, MD; Christian Wittekind, MD; Jean Nicolas Vauthey, MD
Arch Surg. 2008;143(12):1235-1236. doi:10.1001/archsurg.143.12.1235-c.
JAMA Surgery | 
Correspondence |  December 15, 2008
Treatment of Stage IVA Hepatocellular Carcinoma—Reply
Mircea Chirica, MD; Olivier Scatton, MD; Olivier Soubrane, MD
Arch Surg. 2008;143(12):1236. doi:10.1001/archsurg.2008.500.
JAMA Surgery | 
Original Article |  December 15, 2008 FREE
Colorectal Liver Metastases:  Recurrence and Survival Following Hepatic Resection, Radiofrequency Ablation, and Combined Resection–Radiofrequency Ablation
Ana L. Gleisner, MD; Michael A. Choti, MD, MBA; Lia Assumpcao, MD; et al.
Arch Surg. 2008;143(12):1204-1212. doi:10.1001/archsurg.143.12.1204.
JAMA Surgery | 
Original Article |  November 17, 2008 FREE
Hepatectomy for Stage B and Stage C Hepatocellular Carcinoma in the Barcelona Clinic Liver Cancer Classification:  Results of a Prospective Analysis
Guido Torzilli, MD, PhD; Matteo Donadon, MD; Matteo Marconi, MD; et al.
Arch Surg. 2008;143(11):1082-1090. doi:10.1001/archsurg.143.11.1082.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Surgery
Original Article  |  May 8, 2013
Long-term Outcomes Following Tumor Ablation for Treatment of Bilateral Colorectal Liver Metastases
Paul J. Karanicolas, MD, PhD; William R. Jarnagin, MD; Mithat Gonen, PhD; et al.
JAMA Surgery
Invited Critique  |  May 8, 2013
To Ablate or Not to Ablate?: That Is the Question:  Comment on “Tumor Ablation Outcomes Following Tumor Ablation for Treatment of Bilateral Colorectal Liver Metastases”
Karen L. Sherman, MD; David J. Bentrem, MD, MS
JAMA Ophthalmology
Clinical Sciences  |  February 7, 2013
Progression of Ocular Melanoma Metastasis to the Liver:  The 2012 Zimmerman Lecture
Hans E. Grossniklaus, MD
JAMA Surgery
Invited Critique  |  April 01, 2013
Treatment Sequence for Colorectal Cancer With Hepatic Metastases:  Comment on “The Liver-First Approach to the Management of Colorectal Cancer With Synchronous Hepatic Metastases”
Andrew Klein, MD, MBA
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems